YAR:EURONEXT OSLOYara International ASA Analysis
Data as of 2026-05-29 - not real-time
€13.60
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading well above its 20‑day and 50‑day moving averages, confirming a bullish price momentum. The MACD histogram remains positive, and the signal line is bullish, reinforcing the upward trend. However, the RSI has climbed into overbought territory, suggesting a potential short‑term pullback. Volume has been stable, indicating that the recent price gains are supported by consistent buying interest. The price sits near the upper end of its 52‑week range, close to a key resistance level identified by the model. Overall, the technical picture points to continued strength but with caution for a near‑term correction.
Fundamentally, the REIT carries a high forward P/E relative to its industry peers, implying that the market is pricing in strong growth expectations. The dividend yield is markedly high, and the payout ratio is exceptionally low, indicating that the current distribution is well‑covered by cash flow. Recent news highlights a $1.3 billion joint venture with EQT, which should bolster AFFO and expand the cold‑storage footprint. Despite a modest revenue growth rate, the company posted a positive AFFO per share that beat consensus estimates. The discounted cash‑flow model values the shares at roughly half the current market price, flagging a potential overvaluation. Given the blend of solid dividend income, strategic expansion, and elevated valuation, investors should weigh income appeal against price risk.
Fundamentally, the REIT carries a high forward P/E relative to its industry peers, implying that the market is pricing in strong growth expectations. The dividend yield is markedly high, and the payout ratio is exceptionally low, indicating that the current distribution is well‑covered by cash flow. Recent news highlights a $1.3 billion joint venture with EQT, which should bolster AFFO and expand the cold‑storage footprint. Despite a modest revenue growth rate, the company posted a positive AFFO per share that beat consensus estimates. The discounted cash‑flow model values the shares at roughly half the current market price, flagging a potential overvaluation. Given the blend of solid dividend income, strategic expansion, and elevated valuation, investors should weigh income appeal against price risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical setup with overbought RSI
- Current price near resistance
- High forward valuation relative to peers
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic $1.3 billion joint venture expanding cold‑storage capacity
- Strong dividend yield with low payout ratio
- Positive AFFO beating estimates
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustainable dividend income
- Potential overvaluation risk persisting
- Stable cash flow from REIT operations
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin-4.29%
P/E Ratio52.3
ROE-3.70%
ROA1.35%
Debt/Equity159.41
P/B Ratio1.6
Op. Cash Flow€369.3M
Free Cash Flow€475.5M
Industry P/E32.4
Technical Analysis
TrendBullish
RSI72.8
Support€10.10
Resistance€13.70
MA 20€12.30
MA 50€11.02
MA 200€10.92
MACDBullish
VolumeStable
Fear & Greed Index94.09
Valuation
Fair Value€6.40
GradeOvervalued
TypeValue
Dividend Yield5.86%
Risk Assessment
Beta0.48
Volatility58.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.